FDA clears common blood cell count test
The U.S. Food and Drug Administration (FDA) cleared a complete blood cell count (CBC) test that, based on its categorization, can be run in more health care settings, including physicians’ offices, clinics or other types of health care facilities, by a wider range of personnel (e.g. support staff). This broadened test access will allow for faster availability of results. Details at fda.gov.
'Healthier alternative' status of e-cigarettes challenged in new study
The study looked at immune changes in the airways of the lungs and has challenged the idea that e-cigarettes are less harmful to health than conventional tobacco cigarettes. In a paper about to be published in the American Journal of Respiratory and Critical Care Medicine, researchers from the University of North Carolina at Chapel Hill report what they believe to be the first study to use human airway samples to examine the effects of electronic cigarettes. The airway samples from the e-cigarette users had markers of abnormal "neutrophilic response and altered mucin secretion," note the authors. More Information.
Deaths Rates of Liver Cirrhosis Exceed Those of 5 Major Cancers
A new study found that liver cirrhosis mortality is greater than that of five major cancers. The study, sponsored by the Korean Association for the Study of the Liver and the Korean Liver Foundation, was conducted in response to the low survival rate of liver cirrhosis patients and the need to design improved health policy regarding this condition. The researchers, from the Republic of Korea, estimated the mortality of liver cirrhosis and compared it to that of five major cancers: lung, colorectal, stomach, liver and breast. The study was presented at the AASLD Liver Meeting.